|
[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Blum, H.E. (2005) Hepatocellular Carcinoma: Therapy and Prevention. World Journal of Gastroenterology, 11, 7391-7400.
|
|
[3]
|
夏永祥, 张峰, 李相成, 等. 原发性肝癌10 966例外科治疗分析[J]. 中华外科杂志, 2021, 59(1): 6-17.
|
|
[4]
|
Yin, Z., Jin, H., Ma, T., et al. (2018) A Meta-Analysis of Long-Term Survival Outcomes between Surgical Resection and Radiofrequency Ablation in Patients with Single Hepatocellular Carcinoma ≤ 2 cm (BCLC Very Early Stage). International Journal of Surgery, 56, 61-67. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Wang, L., Liu, Z., Liu, X., Zeng, Y. and Liu, J. (2017) The Hepatectomy Efficacy of Huge Hepatocellular Carcinoma and Its Risk Factors: A Meta Analysis. Medicine, 96, e9226. [Google Scholar] [CrossRef]
|
|
[6]
|
Yamamoto, J., Kosuge, T., Takayama, T., et al. (1996) Re-currence of Hepatocellular Carcinoma after Surgery. British Journal of Surgery, 83, 1219-1222. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Coussens, L.M. and Werb, Z. (2002) Inflammation and Cancer. Nature, 420, 860-867. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Del Campo, J.A., Gallego, P. and Grande, L. (2018) Role of Inflamma-tory Response in Liver Diseases: Therapeutic Strategies. World Journal of Hepatology, 10, 1-7. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Piñero, F., Dirchwolf, M. and Pessôa, M.G. (2020) Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment. Cells, 9, Article No. 1370. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Li, X., Chen, Q., Bi, X., et al. (2021) Preoperatively Elevated RDW-SD and RDW-CV Predict Favorable Survival in Intrahepatic Cholangiocarcinoma Patients after Curative Resection. BMC Surgery, 21, Article No. 105. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Hu, L., Li, M., Ding, Y., et al. (2017) Prognostic Value of RDW in Cancers: A Systematic Review and Meta-Analysis. Oncotarget, 8, 16027-16035. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
谢荣华, 范久波. 肝病患者血液检查4项指标变化的临床意义[J]. 现代中西医结合杂志, 2006, 15(9): 1225-1226.
|
|
[13]
|
李霞. 红细胞体积分布宽度与慢性乙型肝炎临床意义的关系[J]. 河北医药, 2012, 34(19): 2980.
|
|
[14]
|
Zhao, T., Cui, L. and Li, A. (2016) The Significance of RDW in Patients with Hepatocellular Carcinoma after Radical Resection. Cancer Biomarkers, 16, 507-512. [Google Scholar] [CrossRef]
|
|
[15]
|
Howell, J., Pinato, D.J., Ramaswami, R., et al. (2017) Integration of the Cancer-Related Inflammatory Response as a Stratifying Biomarker of Survival in Hepatocellular Carcinoma Treated with Sorafenib. Oncotarget, 8, 36161-36170. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Ignacio De Ulíbarri, J., González-Madroño, A., De Villar, N.G.P., et al. (2005) CONUT: A Tool for Controlling Nutritional Status. First Validation in a Hospital Population. Nutricion Hospitalaria, 20, 38-45.
|
|
[17]
|
Nakagomi, A., Kohashi, K., Morisawa, T., et al. (2016) Nutritional Status Is Associated with Inflammation and Predicts a Poor Outcome in Patients with Chronic Heart Failure. Journal of Atherosclerosis and Thrombosis, 23, 713-727. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Narumi, T., Arimoto, T., Funayama, A., et al. (2013) The Prognostic Im-portance of Objective Nutritional Indexes in Patients with Chronic Heart Failure. Journal of Cardiology, 62, 307-313. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Yıldırım, B., Biteker, F.S., Acar, E. and Demir, A. (2020) Con-trolling Nutritional Status Score: A Novel Prognostic Marker for Patients with Community-Acquired Pneumonia. Hong Kong Journal of Emergency Medicine, 28, 227-232. [Google Scholar] [CrossRef]
|
|
[20]
|
Kuroda, D., Sawayama, H., Kurashige, J., et al. (2018) Control-ling Nutritional Status (CONUT) Score Is a Prognostic Marker for Gastric Cancer Patients after Curative Resection. Gastric Cancer, 21, 204-212. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Tokunaga, R., Sakamoto, Y., Nakagawa, S., et al. (2017) CONUT: A Novel Independent Predictive Score for Colorectal Cancer Patients Undergoing Potentially Curative Resection. International Journal of Colorectal Disease, 32, 99-106. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Toyokawa, T., Kubo, N., Tamura, T., et al. (2016) The Pre-treatment Controlling Nutritional Status (CONUT) Score Is an Independent Prognostic Factor in Patients with Resectable Thoracic Esophageal Squamous Cell Carcinoma: Results from a Retrospective Study. BMC Cancer, 16, Article No. 722. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Takagi, K., Yagi, T., Umeda, Y., et al. (2017) Preoperative Controlling Nutritional Status (CONUT) Score for Assessment of Prognosis Following Hepatectomy for Hepatocellular Carcinoma. World Journal of Surgery, 41, 2353-2360. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Yılmaz, A., Tekin, S.B., Bilici, M. and Yılmaz, H. (2020) The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer. Lung, 198, 695-704. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Harimoto, N., Yoshizumi, T., Inokuchi, S., Itoh, S., et al. (2018) Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multi-Institutional Study. Annals of Surgical Oncology, 25, 3316-3323. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Li, L., Liu, C., Yang, J., et al. (2018) Early Postoperative Con-trolling Nutritional Status (CONUT) Score Is Associated with Complication III-V after Hepatectomy in Hepatocellular Carcinoma: A Retrospective Cohort Study of 1, 334 Patients. Scientific Reports, 8, Article No. 13406. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Miyata, T., Yamashita, Y.-I., Higashi, T., et al. (2018) The Prognostic Impact of Controlling Nutritional Status (CONUT) in Intrahepatic Cholangiocarcinoma Following Curative Hepatectomy: A Retrospective Single Institution Study. World Journal of Surgery, 42, 1085-1091. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Zheng, Y., Wu, F., Rong, W., et al. (2020) Prognostic Value of the Controlling Nutritional Status (CONUT) Score in Intrahepatic Cholangiocarcinoma Patients Especially Who Had Long-Time Alcohol Consumption. Journal of Clinical Biochemistry and Nutrition, 67, 323-331. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Coffelt, S.B., Kersten, K., Doornebal, C.W., et al. (2015) IL-17-Producing γδT Cells and Neutrophils Conspire to Promote Breast Cancer Metastasis. Nature, 522, 345-348. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Zahorec, R. (2001) Ratio of Neutrophil to Lymphocyte Counts—Rapid and Simple Parameter of Systemic Inflammation and Stress in Critically Ill. Bratislavské Lekárske Listy, 102, 5-14.
|
|
[31]
|
Templeton, A.J., Mcnamara, M.G., Šeruga, B., et al. (2014) Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. Journal of the National Cancer Institute, 106, dju124. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Peng Y, Li Y, He Y, et al. (2018) The Role of Neutrophil to Lymphocyte Ratio for the Assessment of Liver Fibrosis and Cirrhosis: A Systematic Review. Expert Review of Gastroenterology & Hepatology, 12, 503-513. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Johnson, P.J., Dhanaraj, S., Berhane, S., Bonnett, L. and Ma, Y.T. (2021) The Prognostic and Diagnostic Significance of the Neutrophil-to-Lymphocyte Ratio in Hepatocellular Carcinoma: A Prospective Controlled Study. British Journal of Cancer, 125, 714-716. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Arvanitakis, K., Mitroulis, I. and Germanidis, G. (2021) Tu-mor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy. Cancers, 13, Article No. 2899. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Xu, Z.-G., Ye, C.-J., Liu, L.-X., et al. (2018) The Pretransplant Neutrophil-Lymphocyte Ratio as a New Prognostic Predictor after Liver Transplantation for Hepatocellular Cancer: A Systematic Review and Meta-Analysis. Biomarkers in Medicine, 12, 189-199. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Hu, J., Wang, N., Yang, Y., Ma, L., Han, R., et al. (2018) Diagnostic Value of Alpha-Fetoprotein Combined with Neutrophil-to-Lymphocyte Ratio for Hepatocellular Carcinoma. BMC Gastroenterology, 18, Article No. 186. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Liao, W., Zhang, J., Zhu, Q., et al. (2014) Preoperative Neutro-phil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection. Trans-lational Oncology, 7, 248-255. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Li, B., Zhou, P., Liu, Y., et al. (2018) Platelet-to-Lymphocyte Ratio in Advanced Cancer: Review and Meta-Analysis. Clinica Chimica Acta, 483, 48-56. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Diem, S., Schmid, S., Krapf, M., et al. (2017) Neutro-phil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as Prognostic Markers in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Nivolumab. Lung Cancer, 111, 176-181. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Zhang, Y., Zheng, L., Quan, L. and Du, L. (2021) Prognostic Role of Platelet-to-Lymphocyte Ratio in Oral Cancer: A Meta-Analysis. Journal of Oral Pathology & Medicine, 50, 274-279. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Lin, W.-F., Zhong, M.-F., Zhang, Y.-R., et al. (2018) Prognostic Role of Platelet-to-Lymphocyte Ratio in Hepatocellular Carcinoma with Different BCLC Stages: A Systematic Review and Meta-Analysis. Gastroenterology Research and Practice, 2018, Article ID: 5670949. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Ma, W., Zhang, P., Qi, J., et al. (2016) Prognostic Value of Platelet to Lymphocyte Ratio in Hepatocellular Carcinoma: A Meta-Analysis. Scientific Reports, 6, Article No. 35378. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Chen, Y., Zeng, J., Guo, P., Zeng, J. and Liu, J. (2021) Prognostic Signif-icance of Platelet-to-Lymphocyte Ratio (PLR) in Extrahepatic Metastasis of Hepatocellular Carcinoma after Curative Resection. Cancer Management and Research, 13, 1395-405. [Google Scholar] [CrossRef]
|
|
[44]
|
Xue, T.-C., Jia, Q.-A., Ge, N.-L., et al. (2015) The Platelet-to-Lymphocyte Ratio Predicts Poor Survival in Patients with Huge Hepatocellular Carcinoma That Received Transarterial Chemoembolization. Tumor Biology, 36, 6045-6051. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Bambace, N.M. and Holmes, C.E. (2011) The Platelet Contribu-tion to Cancer Progression. Journal of Thrombosis and Haemostasis, 9, 237-249. [Google Scholar] [CrossRef] [PubMed]
|